Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Filamon LTD
Atavistik Bio, Inc
Astellas Pharma Inc
PMV Pharmaceuticals, Inc
AstraZeneca
University of California, Davis
Roswell Park Cancer Institute
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Rutgers, The State University of New Jersey
Eli Lilly and Company
UMC Utrecht
BeOne Medicines
Aveni Foundation
Bayer
Monte Rosa Therapeutics, Inc
Psyence Australia Pty Ltd
ViroMissile, Inc.
University of Virginia
Malatya Turgut Ozal University
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Kaiser Permanente
Case Comprehensive Cancer Center
Institute of Oncology Ljubljana
National Institutes of Health Clinical Center (CC)
Novartis
Duke University
Washington University School of Medicine
University of Florida
AstraZeneca
Myeloid Therapeutics